Free delivery nationwide for orders above ₱800

 
SAPHMIR-ZARFGQ

SAPHMIRATE-T50 Butamirate Citrate 50mg Sustained Release Tablet 1's

Selling for 1500
1800
You save: 3.00
Out of stock
Discreet Packaging
FDA-registered Products
FDA-licensed Pharmacies
Description

Indications

Symptomatic treatment of acute cough of any origin. Used for cough sedation before and after operation.
 

Dosage

Adult: As 50 mg tab: 2 or 3 tabs daily at intervals of 8 or 12 hours. As 7.5 mg/5 mL syr: 22.5 mg (15 mL) up to 4 times daily. Max: 90 mg (60 mL) daily.
 

Administration

Administer with or without food.
 

Contraindications

Hypersensitivity to any component of the formulation. Refer to manufacturer labeling for further detail.
 

Pregnancy Interactions

Contraindicated: 1st trimester of pregnancy
 

Special Precautions

Hepatic and renal impairment. Pregnancy and lactation.
 

Storage

Store below 30°C.
 

MedsGo Class

Cough & Cold Preparations

Features

Brand
SAPHMIRATE-T50
Full Details
Dosage Strength
50mg
Drug Ingredients
  • Butamirate Citrate
Drug Packaging
Sustained Release Tablet 1's
Generic Name
Butamirate Citrate
Dosage Form
Sustained Release Tablet
Registration Number
DRP-9828
Drug Classification
Over-The-Counter (OTC)
Find similar